Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
The results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available ...
As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results